Lenalidomide in the treatment of anti‐myelin‐associated glycoprotein neuropathy: A phase 1 study to identify the maximum tolerated dose by Stino, Amro M., Bumma, Naresh, Smith, Rachel, Davalos, Long, Allen, Jeff, Ye, Jing Christine, Pianko, Matthew, Campagnaro, Erica, Fierro, Cassandra, Awad, Abdelrahman, Murdock, Ben, Pietrzak, Maciej, Loszanski, Gerard, Kline, David M., Efebera, Yvonne, Elsheikh, Bakri

Get full text